Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium
- PMID: 19330340
- DOI: 10.1007/s00401-009-0523-2
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium
Abstract
When 22 members of the BrainNet Europe (BNE) consortium assessed 31 cases with alpha-synuclein (alphaS) immunoreactive (IR) pathology applying the consensus protocol described by McKeith and colleagues in 2005, the inter-observer agreement was 80%, being lowest in the limbic category (73%). When applying the staging protocol described by Braak and colleagues in 2003, agreement was only 65%, and in some cases as low as 36%. When modifications of these strategies, i.e., McKeith's protocol by Leverenz and colleagues from 2009, Braak's staging by Müller and colleagues from 2005 were applied then the agreement increased to 78 and 82%, respectively. In both of these modifications, a reduced number of anatomical regions/blocks are assessed and still in a substantial number of cases, the inter-observer agreement differed significantly. Over 80% agreement in both typing and staging of alphaS pathology could be achieved when applying a new protocol, jointly designed by the BNE consortium. The BNE-protocol assessing alphaS-IR lesions in nine blocks offered advantages over the previous modified protocols because the agreement between the 22 observers was over 80% in most cases. Furthermore, in the BNE-protocol, the alphaS pathology is assessed as being present or absent and thus the quality of staining and the assessment of the severity of alphaS-IR pathology do not alter the inter-observer agreement, contrary to other assessment strategies. To reach these high agreement rates an entity of amygdala-predominant category was incorporated. In conclusion, here we report a protocol for assessing alphaS pathology that can achieve a high inter-observer agreement for both the assignment to brainstem, limbic, neocortical and amygdala-predominant categories of synucleinopathy and the Braak stages.
Similar articles
-
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study.Acta Neuropathol. 2021 Feb;141(2):159-172. doi: 10.1007/s00401-020-02255-2. Epub 2021 Jan 5. Acta Neuropathol. 2021. PMID: 33399945 Free PMC article.
-
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.Acta Neuropathol. 2008 Apr;115(4):399-407. doi: 10.1007/s00401-008-0346-6. Epub 2008 Feb 23. Acta Neuropathol. 2008. PMID: 18297293 Free PMC article.
-
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Acta Neuropathol. 2016 Jan;131(1):49-73. doi: 10.1007/s00401-015-1485-1. Epub 2015 Oct 7. Acta Neuropathol. 2016. PMID: 26446103 Free PMC article. Review.
-
Lewy body-related alpha-synucleinopathy in the aged human brain.J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. doi: 10.1007/s00702-004-0138-7. Epub 2004 Apr 2. J Neural Transm (Vienna). 2004. PMID: 15480835
-
Formation and development of Lewy pathology: a critical update.J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. J Neurol. 2009. PMID: 19711116 Review.
Cited by
-
Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.Acta Neuropathol. 2024 Jan 10;147(1):14. doi: 10.1007/s00401-023-02657-y. Acta Neuropathol. 2024. PMID: 38198008 Free PMC article.
-
Alpha-synuclein spreading in Parkinson's disease.Front Neuroanat. 2014 Dec 18;8:159. doi: 10.3389/fnana.2014.00159. eCollection 2014. Front Neuroanat. 2014. PMID: 25565982 Free PMC article. Review.
-
Alcohol consumers with liver pathology rarely display α-synuclein pathology.Acta Neuropathol. 2024 Aug 1;148(1):13. doi: 10.1007/s00401-024-02772-4. Acta Neuropathol. 2024. PMID: 39085656 Free PMC article.
-
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099. Brain. 2019. PMID: 31039256 Free PMC article.
-
Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study.Neuroimage Clin. 2013 Apr 11;2:612-9. doi: 10.1016/j.nicl.2013.04.003. eCollection 2013. Neuroimage Clin. 2013. PMID: 24179812 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical